Clinical Trial Update: MaxAn Post Market Surveillance Validation

View source ↗

Summary

A post-market surveillance validation trial update for MaxAn, completed with posted results in 2020, related to conditions including degenerative disc disease (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deformity
• Degenerative Disc Disease

Drugs mentioned

• MaxAn

Snippet

Sponsor: Zimmer Biomet | Conditions: DDD, Deformity | Status: COMPLETED | Results posted: 2020-01-06